Medicinal Compositions of Long Stephania Herb Exhibit Antilung Cancer Effects
Advances in Pharmacological and Pharmaceutical Sciences · 2026-01 · 2026 (1)
DOI: 10.1155/adpp/8058846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Pharmacological and Pharmaceutical Sciences, online erschienen am 28.10.2026. Verfasst von Xiaobing Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Tropical Translational Medicine Ministry of Education, and Hainan Provincial Key Laboratory of Carcinogenesis and Intervention Hain…. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hainan Province.
Abstract (Originalsprache)
Lung cancer is one of the most common malignancies worldwide, and due to its high mortality rate and resistance to treatment, there is an urgent need to develop effective treatments with low toxicity. Long stephania herb (LSH) is a tropical herb used clinically for the treatment of inflammation and analgesia, but its antitumor effects are unknown. In this study, UHPLC–OE–MS was used to detect the chemical components of LSH; the cytotoxic effects of these chemical components on normal lung cells and non‐small cell lung cancer (NSCLC) cell lines were observed in vitro cell experiments, and the inhibitory effects of LSH on the growth of NSCLC were detected in animal tumor models. The possible molecular targets of LSH for NSCLC were predicted by network pharmacology and molecular docking. The results showed that LSH has more than a thousand chemical components; at the microgram level per milliliter, it can effectively inhibit the proliferation, migration, and invasion of lung cancer A549 cells and promote apoptosis in these cells. It also can effectively inhibit the growth of tumors in vivo and has no significant toxic effects on normal lungs, liver, heart, and kidneys. Analysis showed that 20 pharmacodynamic components of LSH may target EGFR, PIK3CA, PIK3R1, AKT1, HSP90AA1, SRC, MAPK1, MAPK3, STAT3, JUN, and CASP3. Inhibition of the PI3K/AKT signaling pathway and proteoglycans in cancer and other signaling pathways plays an anti‐NSCLC role. In conclusion, this study is the first to report the efficacy of LSH in the treatment of NSCLC, and it is a very valuable tropical medicinal plant for the treatment of lung cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Tropical Translational Medicine Ministry of Education, and Hainan Provincial Key Laboratory of Carcinogenesis and Intervention Hainan Medical University Haikou 571199 Hainan China hainmc.edu.cn.
- Department of Respiratory and Critical Care Medicine Hainan General Hospital Hainan Affiliated Hospital of Hainan Medical University Haikou 570311 Hainan China hyfyuan.com.
- Department of Medical Oncology Second Affiliated Hospital Hainan Medical University Haikou 570216 Hainan China hainmc.edu.cn.
ORCID-Profile: Xiaobing Chen, Luying Zhang, Wanying Zhang, Xueqin Wu, Kun Liu, Yuli Zhou, Yongqing Chen, Mingyue Zhu, Bo Lin, Mengsen Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hainan Province
Zitieren
APA
Chen, X., Zhang, L., Zhang, W., Wu, X., Liu, K., Zhou, Y., Chen, Y., Zhu, M., Lin, B., & Li, M. (2026). Medicinal Compositions of Long Stephania Herb Exhibit Antilung Cancer Effects. Advances in Pharmacological and Pharmaceutical Sciences, 2026(1). https://doi.org/10.1155/adpp/8058846
Vancouver
Chen X, Zhang L, Zhang W, Wu X, Liu K, Zhou Y, et al. Medicinal Compositions of Long Stephania Herb Exhibit Antilung Cancer Effects. Advances in Pharmacological and Pharmaceutical Sciences. 2026;2026(1). doi:10.1155/adpp/8058846
BibTeX
@article{Chen2026,
author = {Chen, Xiaobing and Zhang, Luying and Zhang, Wanying and Wu, Xueqin and Liu, Kun and Zhou, Yuli and Chen, Yongqing and Zhu, Mingyue and Lin, Bo and Li, Mengsen},
title = {Medicinal Compositions of Long Stephania Herb Exhibit Antilung Cancer Effects},
journal = {Advances in Pharmacological and Pharmaceutical Sciences},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/adpp/8058846}
}
EUVIMED